Workflow
Arbutus Biopharma(ABUS) - 2025 Q2 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the quarterly period ended June 30, 2025 (Exact Name of Registrant as Specified in Its Charter) British Columbia, Canada 98-0597776 (State or Other Jurisdiction of (I.R.S. Employer Incorporation or Organization) Identification No.) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-34949 ARBUTUS BIOPHARMA CORPORATION ☒ ...